بدائل البحث:
significant new » significant non (توسيع البحث), significant genes (توسيع البحث), significant anti (توسيع البحث)
point decrease » point increase (توسيع البحث)
new decrease » nn decrease (توسيع البحث), we decrease (توسيع البحث), teer decrease (توسيع البحث)
significant new » significant non (توسيع البحث), significant genes (توسيع البحث), significant anti (توسيع البحث)
point decrease » point increase (توسيع البحث)
new decrease » nn decrease (توسيع البحث), we decrease (توسيع البحث), teer decrease (توسيع البحث)
-
1
-
2
-
3
-
4
B2 decreases glycolytic intermediates in cells.
منشور في 2025"…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …"
-
5
-
6
-
7
-
8
-
9
MiR-129-5p levels were decreased in mouse depression models.
منشور في 2025"…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. The gray points represent miRNAs with no significant change (p < 0.05, false discovery rate (FDR) q < 0.05), while red and blue points indicate upregulated and downregulated miRNAs (p < 0.05, FDR q < 0.05), respectively. …"
-
10
-
11
Significant cholesterol genes arranged by day.
منشور في 2024"…Color represents the P-value; red points have P-values ≤ 0.05, and grey points have P-values > 0.05. …"
-
12
-
13
-
14
Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups.
منشور في 2025الموضوعات: -
15
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
-
16
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
17
-
18
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
19
-
20